Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Authors:
- Goushi MatamaGMGoushi Matama
- Masaki OkamotoMOMasaki Okamoto
- Kiminori FujimotoKFKiminori Fujimoto
- Takeshi JohkohTJTakeshi Johkoh
- Masaki TominagaMTMasaki Tominaga
- Hiroshi MukaeHMHiroshi Mukae
- Noriho SakamotoNSNoriho Sakamoto
- Kosaku KomiyaKKKosaku Komiya
- Kenji UmekiKUKenji Umeki
- Masamichi KomatsuMKMasamichi Komatsu
- Yasuo ShimizuYSYasuo Shimizu
- Koichiro TakahashiKTKoichiro Takahashi
Open Access
- 15 November 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7100
Abstract
Periostin was investigated as a biomarker for rheumatoid arthritis-associated interstitial lung disease (RA-ILD). This prospective study measured serum monomeric and total periostin, Klebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), and lactate dehydrogenase (LDH) in 19 patients with RA-ILD, 20 RA without ILD, and 137 healthy controls (HC). All biomarkers were higher in RA-ILD than HC or RA without ILD. KL-6 accurately detected ILD in RA patients (area under curve [AUC] = 0.939) and moderately detected SP-D and monomeric and total periostin (AUC = 0.803, =0.767, =0.767, respectively). Monomeric and total periostin were negatively correlated with normal lung area and positively correlated with honeycombing, reticulation, fibrosis score, and the traction bronchiectasis grade but not inflammatory areas. Serum levels of SP-D, KL-6, and LDH did not correlate with the extent of those fibrotic areas on high-resolution CT. Serum monomeric and total periostin were higher in patients with RA-ILD with definite usual interstitial pneumonia pattern compared with other ILD patterns. Immunohistochemical analyses of biopsy or autopsy lung tissues from RA-ILD during the chronic phase and acute exacerbation showed that periostin was expressed in fibroblastic foci but not inflammatory or dense fibrosis lesions. Periostin is a potential biomarker for diagnosis, evaluating fibrosis, and deciding therapeutic strategies for patients with RA-ILD.Keywords
Funding Information
- Grant-in-Aid for Scientific Research (C) (19K08637, 22K08248)
- Kakihara Science Technology Foundation (19K08637, 22K08248)
- Division of Respirology, Rheumatology, and Neurology, Department of Internal Medicine, Kurume University School of Medicine (19K08637, 22K08248)
- Shino-Test Co., Ltd. (19K08637, 22K08248)
This publication has 40 references indexed in Scilit:
- Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control studyBMJ Open, 2013
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumoniasEuropean Respiratory Journal, 2010
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRAScandinavian Journal of Rheumatology, 2010
- Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohortRheumatology, 2010
- Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2010
- Acute Exacerbations of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosisRespirology, 2006
- Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2002